DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+3.12%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$1.35B
AUM Growth
–
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
44.69%
Holding
53
New
49
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$76.1M |
| 2 |
Travere Therapeutics
TVTX
|
$76M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$67M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$66.9M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$63.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.89% |
| 2 | Real Estate | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dianthus Therapeutics
DNTH
$759M
| $21.6M | 1.52% | +4,870,000 | New | +$21.6M |
|
|
SAGE
27
DELISTED
Sage Therapeutics
SAGE
| $21.3M | 1.5% | +500,000 | New | +$21.3M |
|
28
Passage Bio
PASG
$22.7M
| $20.4M | 1.44% | +3,216,997 | New | +$20.4M |
|
29
KalVista Pharmaceuticals
KALV
$678M
| $19.8M | 1.4% | +1,500,000 | New | +$19.8M |
|
30
Nkarta
NKTX
$151M
| $19.4M | 1.37% | +1,264,426 | New | +$19.4M |
|
|
VERV
31
DELISTED
Verve Therapeutics
VERV
| $18.4M | 1.3% | +500,000 | New | +$18.4M |
|
|
KRTX
32
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $17.1M | 1.2% | +130,200 | New | +$17.1M |
|
33
Tenaya Therapeutics
TNYA
$184M
| $14.4M | 1.02% | +762,317 | New | +$14.4M |
|
34
Protagonist Therapeutics
PTGX
$3.67B
| $14.4M | 1.02% | +421,660 | New | +$14.4M |
|
35
Fulcrum Therapeutics
FULC
$351M
| $13.3M | 0.94% | +750,000 | New | +$13.3M |
|
|
SRRA
36
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $13.2M | 0.93% | +607,600 | New | +$13.2M |
|
37
Acumen Pharmaceuticals
ABOS
$82.4M
| $13.1M | 0.92% | +1,933,040 | New | +$13.1M |
|
38
Atara Biotherapeutics
ATRA
$84.6M
| $11.8M | 0.83% | +750,000 | New | +$11.8M |
|
39
GH Research
GHRS
$837M
| $11.7M | 0.82% | +499,400 | New | +$11.7M |
|
40
Ascendis Pharma
ASND
$11.8B
| $10.8M | 0.76% | +80,000 | New | +$10.8M |
|
|
ATYR
41
aTyr Pharma
ATYR
$527M
| $8.22M | 0.58% | +1,100,000 | New | +$8.22M |
|
42
Vanda Pharmaceuticals
VNDA
$279M
| $7.85M | 0.55% | +500,000 | New | +$7.85M |
|
43
Assembly Biosciences
ASMB
$190M
| $6.99M | 0.49% | +3,000,000 | New | +$6.99M |
|
|
CNTA
44
Centessa Pharmaceuticals
CNTA
$2.25B
| $4.5M | 0.32% | +400,000 | New | +$4.5M |
|
|
TECX
45
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $4.04M | 0.29% | +1,050,132 | New | +$4.04M |
|
46
Century Therapeutics
IPSC
$42.5M
| $3.97M | 0.28% | +250,000 | New | +$3.97M |
|
|
CNTB
47
Connect Biopharma
CNTB
$115M
| $3.33M | 0.24% | +647,057 | New | +$3.33M |
|
|
ONCR
48
DELISTED
Oncorus, Inc.
ONCR
| $3.16M | 0.22% | +600,000 | New | +$3.16M |
|
49
Rafael Holdings
RFL
$51.6M
| $1.46M | 0.1% | +285,714 | New | +$1.46M |
|
50
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | 0 | – | – |
|